Literature DB >> 1636538

MR of primary CNS lymphoma in immunologically normal patients.

S M Roman-Goldstein1, D L Goldman, J Howieson, R Belkin, E A Neuwelt.   

Abstract

PURPOSE: To describe the MR findings of primary CNS lymphoma.
METHODS: MR scans of 20 patients with histologically proved primary CNS lymphoma were reviewed. We evaluated the size, multiplicity, signal intensities, and enhancement characteristics of the lesions. We divided the lesions into an enhancing area referred to as Zone 1 and abnormal signal surrounding this, referred to as Zone 2.
RESULTS: Primary CNS lymphoma presented as solitary enhancing lesions in 40% of the patients and multiple lesions in 40%. Thirty-three separate lesions were visible: 58% abutted the ventricular system, 76% showed a homogenous enhancement pattern, and 79% showed marked enhancement. In 64% of the lesions, Zone 1 and Zone 2 showed different signal intensities on T1-weighted images.
CONCLUSIONS: Primary CNS lymphoma usually presents as solitary or multiple dense homogenous enhancing lesions that abut an ependymal surface. These lesions can be divided into an enhancing area and an area of surrounding abnormal signal. These two areas often have different signal intensities on unenhanced T2-weighted images. These findings are sufficiently suggestive of the diagnosis of primary CNS lymphoma that a needle biopsy be performed based on these findings and appropriate therapy can then be instituted.

Entities:  

Mesh:

Year:  1992        PMID: 1636538      PMCID: PMC8333570     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  17 in total

1.  Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain.

Authors:  R Mangla; B Kolar; T Zhu; J Zhong; J Almast; S Ekholm
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

2.  Usefulness of Ga-67 brain SPECT in patients with CNS malignant lymphoma.

Authors:  H Fujii; S Kosuda; K Suzuki; H Yorino; S Akita; H Negishi; O Nakamura; N Shitara; A Kubo
Journal:  Ann Nucl Med       Date:  1996-11       Impact factor: 2.668

3.  Primary Central Nervous System Lymphoma.

Authors:  Denise M. Damek
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

4.  Nonenhancing primary central nervous system lymphoma.

Authors:  S Terae; A Ogata
Journal:  Neuroradiology       Date:  1996-01       Impact factor: 2.804

5.  Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients.

Authors:  Wilhelm Küker; Thomas Nägele; Agnieska Korfel; Stefan Heckl; Eckhard Thiel; Michael Bamberg; Michael Weller; Ulrich Herrlinger
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

6.  Radiologic morphology of low-grade primary central nervous system lymphoma in immunocompetent patients.

Authors:  Kristoph Jahnke; Andreas Schilling; Jens Heidenreich; Harald Stein; Mario Brock; Eckhard Thiel; Agnieszka Korfel
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

7.  Efficacy of Perfusion Computed Tomography (PCT) in Differentiating High-Grade Gliomas from Low Grade Gliomas, Lymphomas, Metastases and Abscess.

Authors:  Lakshmikanth Halegubbi Karegowda; Rajagopal Kadavigere; Poonam Mohan Shenoy; Samir Mustaffa Paruthikunnan
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 8.  Primary central nervous system lymphoma: from clinical presentation to diagnosis.

Authors:  U Herrlinger; M Schabet; M Bitzer; D Petersen; P Krauseneck
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

9.  High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma.

Authors:  Philipp Kiewe; Christoph Loddenkemper; Ioannis Anagnostopoulos; Mark Reinwald; Eckhard Thiel; Agnieszka Korfel
Journal:  Neuro Oncol       Date:  2007-02-14       Impact factor: 12.300

10.  An adult multifocal medulloblastoma with diffuse acute postoperative cerebellar swelling: immunohistochemical and molecular genetics analysis.

Authors:  Vladimir Balik; Radek Trojanec; Milena Holzerova; Lucie Tuckova; Igor Sulla; Magdalena Megova; Miroslav Vaverka; Lumir Hrabalek; Jiri Ehrmann
Journal:  Neurosurg Rev       Date:  2014-06-10       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.